Ionis Pharmaceuticals Inc (IONS)
81.76
-4.41%
Ionis Pharmaceuticals Inc (IONS) is currently trading at $81.76. This represents a loss of 4.41% from the previous session. With a market capitalization of $13.24B, IONS is a key component of the Health Care sector. Investors looking to trade IONS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade IONS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Ionis Pharmaceuticals Inc (IONS) shows a bearish trend. Analysts are watching the 85.12 level closely.
Fundamentals
Mkt Cap13.24B
P/E Ratio0.0000
Volume1,395,604
60-Day Technical Chart
Advanced Charting
Need more indicators for IONS? Use the world's #1 platform.
Open IONS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $82
| Metric |
IONS -4.41% |
CRCL +28.75% |
NFLX +5.43% |
HOOD +4.76% |
|---|---|---|---|---|
| Price | $81.76 | $79.18 | $82.28 | $76.88 |
| Mkt Cap | $13.24B | $18.61B | $347.00B | $69.24B |
| - | View → | View → | View → |
Latest Headlines
Biotech Ionis beats 2025 goals, readies two new drug launches
Stock Titan • Feb 25, 2026
Ionis Pharmaceuticals (NASDAQ:IONS) Shows High Technical and Setup Ratings for Potential Breakout
ChartMill • Feb 24, 2026
Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 10.19% Potential Upside in the Biotech Frontier
DirectorsTalk Interviews • Feb 23, 2026
Ionis to present at upcoming investor conferences
Business Wire • Feb 19, 2026
Ionis Pharmaceuticals EVP Swayze sells $1.27 million in IONS stock
Investing.com • Feb 13, 2026
● Gemini Agentic AI Analyst Insight for IONS
Market Education
- Exploring Gann Trading: An Insightful Guide for Traders Jun 2, 2024
- What Wolves Can Teach Us About Winning in the Markets Sep 8, 2025
- Canada Pension Plan - Top Stocks Nov 20, 2023
External Research